Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPlant Impact Regulatory News (PIM)

  • There is currently no data for PIM

R&D Platform and Pipeline Presentation

15 Aug 2017 07:00

RNS Number : 9748N
Plant Impact PLC
15 August 2017
 

 

For immediate release

 

15 August 2017

 

RNS Reach

Plant Impact Plc

("Plant Impact" or the "Group")

 

Research & Development Platform and Pipeline Presentation

 

Plant Impact plc (AIM: PIM), a leader in research and development in crop enhancement products that growers can rely on to improve the yield and quality of crops, is pleased to publish the first presentation on its research and development ("R&D") platform and pipeline. The full presentation can be found at

www.plantimpact.com/investors

 

The Group's R&D platform is highly differentiated within the emerging crop enhancement sector and is focused on bringing products to market over the next 5 years, with the first pipeline product expected to launched by 2020. The platform begins with an understanding of key yield-limiting physiological and biochemical plant responses. It then prioritises soybean and wheat as model dicot and monocot crops to enable future diversification into other crops such as cotton and corn, and utilises novel synthetic and small molecule chemistry. This methodology generates targeted foliar and seed treatment products.

 

The R&D presentation sets out the following:

 

· Industry - the case for crop enhancement and the current landscape

· Business - structure and history (with an R&D focus)

· Research and technology - platform design, screening process and the case for chemistry

· Pipeline and products - pipeline stages, case studies and focus areas

· Markets - activity overviews and case studies for key markets

· Financial model - corporate value streams, indicative peak annual sales opportunity for pipeline products and an explanation of revenue streams included/excluded from external guidance

· Market estimates (appendix) - methodology used to estimate the indicative market sizes for R&D focus areas

 

Plant Impact believes that crop enhancement will grow to be a significant sector within the chemical and biological farming inputs market, playing a key role in sustainably improving food security worldwide by using new technologies to help growers improve global crop yields.

 

John Brubaker, CEO, said: "Growth and innovation in the crop enhancement sector is accelerating more rapidly than ever before and at Plant Impact we are proud to be at the forefront of R&D advances in synthetic and small molecule chemistry. This is our first R&D presentation; it establishes a new level of clarity on our pipeline and it will be updated regularly. I would like to thank our shareholders for their continued support."

 

 

For further information, contact:

 

Plant Impact

John Brubaker, Chief Executive Officer Tel: +44(0) 1582 465 540

Richard Amos, Chief Financial Officer

Ailish Tracy, Global Communications Manager

www.plantimpact.com

 

Peel Hunt - Nominated Advisor and Broker

Adrian Trimmings Tel: +44 (0) 207 418 8900

George Sellar

 

Buchanan

Mark Court Tel: +44(0) 20 7466 5000

Jamie Hooper

Sophie Cowles

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALLFETTAISLID
Date   Source Headline
2nd Jul 200910:00 amRNSIssue of Equity
15th Jun 20097:00 amRNSPreliminary Final Results
12th Jun 200911:18 amRNSPlant Impact Announce R & D Collaboration
10th Jun 20097:00 amRNSPlant Impact Announce Validation of PiNT by USDA
1st Jun 20097:00 amRNSLicence Agreement
29th May 20097:00 amRNSTotal Voting Rights
21st May 200910:12 amRNSPlant Impact Announce Field Trial Results
18th May 20093:51 pmRNSExercise of Options
21st Apr 20098:00 amRNSSale of crop nutrient products
26th Mar 20093:33 pmRNSHolding(s) in Company
9th Mar 20097:00 amRNSField Trial Results
20th Feb 200910:00 amRNSLoan Agreement & Exclusive Discussions
13th Feb 20094:17 pmRNSHolding(s) in Company
13th Feb 20093:09 pmRNSHolding(s) in Company
13th Feb 200910:11 amRNSHolding(s) in Company
10th Feb 200912:29 pmRNSDirectorate Change
19th Jan 20092:10 pmRNSHolding(s) in Company
19th Jan 20092:10 pmRNSHolding(s) in Company
5th Jan 20094:24 pmRNSHolding(s) in Company
15th Dec 200810:23 amRNSHolding(s) in Company
9th Dec 20087:00 amRNSHalf Yearly Report
5th Sep 20081:58 pmRNSResult of AGM
3rd Sep 20082:41 pmRNSDirectorate Change
1st Sep 20085:22 pmRNSDirector Declaration
20th Aug 20087:01 amRNSAnnual Report and Accounts
20th Aug 20087:00 amRNSBugoil - submission of regist
11th Aug 20087:00 amRNSNotice of AGM
29th Jul 20082:30 pmRNSHolding(s) in Company
10th Jul 20082:14 pmRNSHolding(s) in Company
23rd Jun 20087:00 amRNSFinal Results
9th Jun 20083:08 pmRNSReplacement -Notice of Result
9th Jun 20087:00 amRNSNotice of Results
12th May 20086:00 amRNSDistribution Agreement
14th Apr 20087:00 amRNSUS Agreement Signed
10th Mar 20087:00 amRNSBugOil Trial Results Update
22nd Feb 20087:00 amRNSHolding(s) in Company
21st Feb 20087:00 amRNSPlacing
11th Dec 20074:26 pmRNSHolding(s) in Company
11th Dec 20074:22 pmRNSHolding(s) in Company
26th Nov 20077:00 amRNSInterim Results
16th Nov 200710:00 amRNSNotice of Results
1st Nov 20077:02 amRNSAnalyst and media site visit
30th Oct 20077:01 amRNSGrape field trial results
8th Oct 20077:01 amRNSSuccessful field trial result
27th Sep 20077:01 amRNSSuccessful field trial result
5th Sep 200711:44 amRNSResult of AGM
21st Aug 200711:08 amRNSAppointment of Joint Broker
17th Aug 20079:46 amRNSAIM Rule 26 Information
2nd Jul 200711:09 amRNSFinal Results 31 March 2007
2nd Jul 20077:01 amRNSAnnual Report and Accounts

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.